Bone cells, sclerostin, and FGF23: what's bred in the bone will come out in the flesh
- PMID: 25723633
- DOI: 10.1038/ki.2014.360
Bone cells, sclerostin, and FGF23: what's bred in the bone will come out in the flesh
Erratum in
-
Bone cells, sclerostin, and FGF23: what's bred in the bone will come out in the flesh.Kidney Int. 2015 Jul;88(1):203. doi: 10.1038/ki.2015.154. Kidney Int. 2015. PMID: 26126105 No abstract available.
Abstract
Bone metabolism is linked to systemic diseases, and new research shows that the bone cells have endocrine functions that affect multiple organs. They secrete sclerostin, FGF23, prostaglandins, and osteocalcin. Pereira et al. examined gene expression of cells grown from bone biopsies of adolescents with renal osteodystrophy, as a first step to understanding how the bone-cell abnormalities contribute to cardiovascular and metabolic problems in these patients.
Comment on
-
Primary osteoblast-like cells from patients with end-stage kidney disease reflect gene expression, proliferation, and mineralization characteristics ex vivo.Kidney Int. 2015 Mar;87(3):593-601. doi: 10.1038/ki.2014.347. Epub 2014 Oct 29. Kidney Int. 2015. PMID: 25354236 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical